Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Diabetes & Endocrinology

  • Home
  • Specialties
  • Diabetes & Endocrinology
  • Page 31
Posted inDiabetes & Endocrinology Infectious Diseases news

Impact of Obesity on Long COVID: Insights from Primate Studies

Posted by MedXY By MedXY 07/25/2025
Obesity influences the long-term effects of SARS-CoV-2, revealing diverse outcomes in primates and suggesting broader implications for humans.
Read More
Posted inDiabetes & Endocrinology news Specialties

Heart Risks Uncovered: Popular Diabetes Drug Glipizide Linked to Higher Cardiovascular Events, Study Reveals

Posted by MedXY By MedXY 07/24/2025
Recent research reveals glipizide, a common diabetes drug, increases cardiovascular risks compared to DPP-4 inhibitors. This challenges assumptions about sulfonylureas, urging personalized treatment considering heart health alongside glycemic control in type 2 diabetes management.
Read More

Posts pagination

Previous page 1 … 29 30 31
  • Digital Vestibular Rehabilitation After Acute Vertigo: What a Negative Superiority Trial Means
  • Restoring Cortisol Rhythm May Be Key to Recovery After Cushing Syndrome
  • Long-term Follow-up of Type 1 Diabetes Immunotherapy Trials Finds Reassuring Safety Signals
  • Long-Term Safety Signals Remain Reassuring in Type 1 Diabetes Immunotherapy Follow-up
  • Mitochondrial Rescue in HFpEF: Elamipretide Restores Skeletal Muscle Performance in a Rat Model
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prevention prostate cancer public health quality of life randomized clinical trial randomized trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in